Komuraiah Myakala et al. found that treatment of type 2 diabetes in db/db mice with nicotinamide riboside (NR) promoted NAD metabolism, increased SIRT3 activity improved mitochondrial function, and reduced inflammation, thereby preventing the progression of DN [45] (Figure 2). This evidence concerns the gene SIRT3 and type 2 diabetes mellitus.